Definitive Healthcare Corp. (DH)
NASDAQ: DH · IEX Real-Time Price · USD
6.99
+0.26 (3.86%)
At close: Apr 26, 2024, 4:00 PM
6.85
-0.14 (-2.00%)
After-hours: Apr 26, 2024, 4:07 PM EDT
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for DH stock have an average target of 10.94, with a low estimate of 9.50 and a high estimate of 13. The average target predicts an increase of 56.51% from the current stock price of 6.99.
Analyst Consensus: Hold
* Price targets were last updated on Mar 1, 2024.
Analyst Ratings
The average analyst rating for DH stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 5 | 5 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +57.37% | Mar 1, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | +43.06% | Feb 29, 2024 |
| Stifel | Stifel | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +57.37% | Jan 17, 2024 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $10 | Strong Buy → Hold | Downgrades | $10 | +43.06% | Jan 5, 2024 |
Financial Forecast
Revenue This Year
274.26M
from 251.42M
Increased by 9.09%
Revenue Next Year
295.41M
from 274.26M
Increased by 7.71%
EPS This Year
0.39
from -1.79
EPS Next Year
0.43
from 0.39
Increased by 11.82%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 281.7M | 307.5M | 353.0M |
| Avg | 274.3M | 295.4M | 324.1M |
| Low | 258.7M | 273.3M | 290.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 12.0% | 12.1% | 19.5% |
| Avg | 9.1% | 7.7% | 9.7% |
| Low | 2.9% | -0.3% | -1.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.40 | 0.48 | 0.55 |
| Avg | 0.39 | 0.43 | 0.49 |
| Low | 0.33 | 0.38 | 0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 24.7% | 26.0% |
| Avg | - | 11.8% | 13.5% |
| Low | - | -1.3% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.